secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2023-03-07T23:59:59+00:00
Accession:  0000950170-23-006384
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo appoints Lamothe COO, Taylor CFO; base salaries $470K and $404K
----------------------------------------------------------------------

- Jeffrey Lamothe promoted from EVP/CFO to EVP/COO; base salary $470,000, bonus target 45%.
- Daphne Taylor promoted from SVP Finance to SVP/CFO; base salary $403,745, bonus target 40%.
- Lamothe received 16,500 options and 16,500 RSUs vesting over 3 years under 2018 Stock Plan.
- Taylor received 11,000 options and 11,000 RSUs vesting over 3 years; effective March 3, 2023.
- No family relationships or reportable transactions involving the appointees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023006384/0000950170-23-006384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000095017023006384/apvo-20230303.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-006384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer